18VAC110-20-323. Scheduling for conformity with federal law or rule.
Pursuant to subsection E of § 54.1-3443 of the Code of Virginia and in order to conform the Drug Control Act to recent scheduling changes enacted in federal law or rule, the board:
1. Adds MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) to Schedule I;
2. Adds Dronabinol ((-)-delta-9-trans tetrahydrocannabinol) in
an oral solution in a drug product approved for marketing by the U.S. Food and
Drug Administration to Schedule II;
3. Deletes naldemedine from Schedule II; and
4. Adds a drug product in finished dosage formulation that has been approved by the U.S. Food and Drug Administration that contains cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) derived from cannabis and no more than 0.1% (w/w) residual tetrahydrocannabinols to Schedule V.